François Schellenberg1, Jos P M Wielders. 1. Laboratory of Biochemistry, hôpital Trousseau, CHRU de Tours, 37044 Tours, France. f.schellenberg@chu-tours.fr
Abstract
BACKGROUND: Carbohydrate-deficient transferrin (CDT) measurement on the multicapillary system Capillarys™ is characterized by high throughput and an on-line sample pre-treatment. This study evaluates the linearity and the precision of this technique, the correlation with the candidate reference method and the effect of genetic transferrin variants. Upper reference limit and cut-off values were calculated. METHODS: The precision study was carried out following CLSI EP5-A protocol. The between laboratory variation was calculated from an eight-site study. The upper reference limit (URL) was conventionally calculated from a reference population of 225 samples and verified by a Bhattacharya analysis in a large (n=19,129) population. A population of 314 heavy consumers was used for calculation of the cut-off limit. Additionally the measurement uncertainty was calculated according to EDMA (European Diagnostic Manufacturers Association) and IRMM. RESULTS: The imprecision found was less than 5%, linearity was excellent for CDT values ranging from 2% to 20%. The between site variation around the cut-off value (CDT ranging from 1.68% to 1.79%) was clinically not significant. The upper reference limit (95th percentile) was calculated at 1.3% by the conventional IFCC method and confirmed by Bhattacharya calculations. The optimum cut-off for this CZE method was 1.6%, taken into account the measurement uncertainty. The regression equation with the candidate reference method was Disialotransferrin(Capillarys2)=Disialotransferrin(HPLC)∗0.968-0.248. Genetic variants and abnormal profiles were well recognized. CONCLUSIONS: These results demonstrate that the Capillarys CDT method is robust and reliable in routine use with a high degree of homogeneity from one system to another and is highly correlated with the candidate HPLC reference method.
BACKGROUND:Carbohydrate-deficient transferrin (CDT) measurement on the multicapillary system Capillarys™ is characterized by high throughput and an on-line sample pre-treatment. This study evaluates the linearity and the precision of this technique, the correlation with the candidate reference method and the effect of genetic transferrin variants. Upper reference limit and cut-off values were calculated. METHODS: The precision study was carried out following CLSI EP5-A protocol. The between laboratory variation was calculated from an eight-site study. The upper reference limit (URL) was conventionally calculated from a reference population of 225 samples and verified by a Bhattacharya analysis in a large (n=19,129) population. A population of 314 heavy consumers was used for calculation of the cut-off limit. Additionally the measurement uncertainty was calculated according to EDMA (European Diagnostic Manufacturers Association) and IRMM. RESULTS: The imprecision found was less than 5%, linearity was excellent for CDT values ranging from 2% to 20%. The between site variation around the cut-off value (CDT ranging from 1.68% to 1.79%) was clinically not significant. The upper reference limit (95th percentile) was calculated at 1.3% by the conventional IFCC method and confirmed by Bhattacharya calculations. The optimum cut-off for this CZE method was 1.6%, taken into account the measurement uncertainty. The regression equation with the candidate reference method was Disialotransferrin(Capillarys2)=Disialotransferrin(HPLC)∗0.968-0.248. Genetic variants and abnormal profiles were well recognized. CONCLUSIONS: These results demonstrate that the Capillarys CDT method is robust and reliable in routine use with a high degree of homogeneity from one system to another and is highly correlated with the candidate HPLC reference method.
Authors: David A Leon; Vladimir M Shkolnikov; Svetlana Borinskaya; Juan-Pablo Casas; Alun Evans; Artyom Gil; Frank Kee; Nikolay Kiryanov; Martin McKee; Mark G O'Doherty; George B Ploubidis; Olga Polikina; Maxim Vassiliev; Stefan Blankenberg; Hugh Watkins Journal: Eur J Epidemiol Date: 2013-05-05 Impact factor: 8.082
Authors: Helen McDonald; Svetlana Borinskya; Nikolay Kiryanov; Artyom Gil; Anders Helander; David A Leon Journal: Addiction Date: 2013-07-05 Impact factor: 6.526
Authors: Karolina Mitusińska; Artur Góra; Anna Bogdańska; Agnieszka Rożdżyńska-Świątkowska; Anna Tylki-Szymańska; Aleksandra Jezela-Stanek Journal: Biomolecules Date: 2022-03-04